Find Clinical Trials

All CategoriesMedications / Interventions»Qq-Rr»Ritonavir



Join Paid Clinical Trials



  • Conditions:   Liver Disease;   Hepatitis D
    Interventions:   Drug: Peg-interferon lambda;   Drug: Lonafarnib;   Drug: Ritonavir
    Sponsor:   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
    Recruiting

  • Conditions:   Hepatitis C;   HIV Coinfection
    Interventions:   Drug: TDF with a boosted protease inhibitor;   Drug: TAF with a boosted protease inhibitor;   Drug: TAF with a boosted protease inhibitor and LDV/SOF
    Sponsor:   University of Colorado, Denver
    Recruiting

  • Condition:   Hepatitis Delta Virus
    Interventions:   Drug: Lonafarnib;   Drug: Ritonavir;   Drug: PEG IFN-alfa-2a;   Drug: Placebo Lonafarnib;   Drug: Placebo Ritonavir
    Sponsor:   Eiger BioPharmaceuticals
    Recruiting

  • Conditions:   Chronic Kidney Disease;   Chronic Hepatitis C
    Interventions:   Drug: Viekira Pak ± ribavirin;   Drug: Mavyret
    Sponsors:   Massachusetts General Hospital;   AbbVie
    Recruiting

  • Condition:   HIV
    Intervention:   Drug: Enfuvirtide
    Sponsor:   Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    Recruiting

  • Condition:   HIV Infections
    Interventions:   Drug: atazanavir/cobicistat;   Drug: darunavir/ritonavir;   Drug: darunavir/cobicistat;   Drug: etravirine;   Drug: elvitegravir/cobicistat;   Drug: dolutegravir;   Drug: tenofovir alafenamide fumarate (TAF);   Drug: TAF/cobicistat;   Drug: TAF/ritonavir;   Drug: efavirenz;   Drug: lopinavir/ritonavir;   Drug: nevirapine;   Drug: rifampicin;   Drug: ethambutol;   Drug: isoniazid;   Drug: pyrazinamide;   Drug: kanamycin;   Drug: amikacin;   Drug: capreomycin;   Drug: moxifloxacin;   Drug: levofloxacin;   Drug: ofloxacin;   Drug: ethionamide/prothionamide;   Drug: terizidone/cycloserine;   Drug: para-aminosalicylic acid (PAS);   Drug: high dose isoniazid (INH);   Drug: bedaquiline;   Drug: clofazamine;   Drug: delamanid;   Drug: linezolid;   Drug: pretomanid;   Drug: atazanavir/ritonavir/tenofovir;   Drug: ethinyl estradiol oral contraceptive;   Drug: etonogestrel implant
    Sponsors:   National Institute of Allergy and Infectious Diseases (NIAID);   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
    Recruiting

  • Condition:   HIV Infection
    Interventions:   Drug: Nucleoside Reverse Transcriptase Inhibitors (NRTIs);   Drug: Nevirapine (NVP);   Drug: Lopinavir/Ritonavir (LPV/r);   Drug: Raltegravir (RAL);   Drug: VRC01
    Sponsors:   National Institute of Allergy and Infectious Diseases (NIAID);   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
    Recruiting

Login to Get Started